Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting β Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice
Background. Progressive β-cell dysfunction, a major characteristic of type 2 diabetes (T2D), is closely related to the infiltration of inflammatory macrophages within islets. Mesenchymal stem cells (MSCs) have been identified to alleviate β-cell dysfunction by modulating macrophage phenotype in T2D,...
Saved in:
Main Authors: | Jing Xue, Yu Cheng, Haojie Hao, Jieqing Gao, Yaqi Yin, Songyan Yu, Junyan Zou, Jiejie Liu, Qi Zhang, Yiming Mu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2020/4689798 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice
by: Bing Li, et al.
Published: (2019-01-01) -
Umbilical Cord Mesenchymal Stem Cells Ameliorate Inflammation-Related Tumorigenesis via Modulating Macrophages
by: Yanxia Fu, et al.
Published: (2022-01-01) -
Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications
by: E. Russo, et al.
Published: (2022-01-01) -
Umbilical Cord as Prospective Source for Mesenchymal Stem Cell-Based Therapy
by: Irina Arutyunyan, et al.
Published: (2016-01-01) -
Urothelial Differentiation of Human Umbilical Cord-Derived Mesenchymal Stromal Cells In Vitro
by: Shuai Wu, et al.
Published: (2013-01-01)